Category: Life Sciences
North America Life Sciences
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. ... Read More
-
Operating Room Integrated Systems
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. HD Display Systems, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.2 Billion by ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Microelectronic Medical Implants
... at a CAGR of 8.0% over the analysis period 2024-2030. Pacemakers & Defibrillators, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$22.7 Billion by the end ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Exosome Research Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by ... Read More
-
Nursing Education Market in US 2025-2029
... the nursing education market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Population Health Management
... at a CAGR of 12.2% over the analysis period 2024-2030. Population Health Management Software, one of the segments analyzed in the report, is expected to record a 13.1% CAGR and reach US$61.7 Billion by the ... Read More
-
Therapeutic Respiratory Devices
... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More
-
Probiotics Dietary Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by the end of ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth ... Read More
-
Generic Drugs
... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More
-
Soldier Systems
... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Clot Management Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Fruit Flavor, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$24.1 Billion by the end of the analysis ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Drug Screening
... CAGR of 16.7% over the analysis period 2024-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$16.7 Billion by the end of the ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
OTT Devices and Services
... 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Video Content, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$252.9 Billion by the ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Photography Equipment
... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
Research Assistance
